Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Price-to-sales ratio
5Y CAGR
+23.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 167.07 | - |
| 2024 | 0.00 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 5.27 | -91.0% |
| 2020 | 58.85 | +939.1% |
| 2019 | 5.66 | -13.1% |
| 2018 | 6.52 | -49.0% |
| 2017 | 12.78 | -29.5% |
| 2016 | 18.12 | - |